Astrana Health, Inc.
corporate_fare Company Profile
Astrana Health, Inc. (NASDAQ:ASTH) is a publicly traded company in the Trade & Services sector. Wiseek has independently scored 18 items for ASTH at importance 7 or higher on its 1–10 market-impact scale. Its most recent item scored 7 or higher is dated 2026-11-06, rated 8/10. Across its 18 most recent items scored 7 or higher, the top rating is 9/10, with 9 rated 8 or above. Recent SEC coverage for ASTH spans 10-Q, 8-K, DEF 14A, S-3ASR.
Recent high-impact activity:
- Astrana Q3 10-Q: Record $1.02B Revenue, But Material Weakness Still Unremediated
- Q3 Revenue Tops $1B as Net Income Jumps 1,782%, FY Guidance Narrowed
- Astrana Health Discloses Material Cybersecurity Incident Involving Unauthorized Data Access
- Astrana Health Q2 Revenue Jumps 49% to $972.5M, but Lingering Material Weakness Tempers the Quarter
- Astrana Health Q2 Revenue Misses, But EPS Crushes Estimates and Guidance Raised
Financial Snapshot
Short Interest & Short Volume
12.28 days to coverFINRA reported short interest of 2,994,790 shares in ASTH as of the October 30, 2026 settlement, a 0.5% decrease from the prior period — about 12.3 days to cover at its recent average daily volume. On November 20, 2026, 62.2% of ASTH volume reported to FINRA trade-reporting facilities was marked short.
Daily short sale volume covers trades reported to FINRA trade-reporting facilities and is not the same as short interest (bi-monthly reported positions). Source: FINRA — FINRA is the owner and source of this short interest and short sale volume data; it may not be redistributed.